Related by context. All words. (Click for frequent words.) 71 Aflibercept 69 Pemetrexed 68 demonstrated antitumor activity 68 Afatinib 68 CIMZIA TM certolizumab pegol 68 sorafenib Nexavar 68 epoetin alpha 68 zonisamide SR 68 Sanofi Pasteur Fluzone 67 cisplatin gemcitabine 67 Tarceva TM 67 biologic DMARD 67 Engerix B 67 phase IIIb 67 TBC# 67 Dabigatran etexilate 67 Xeloda ® 67 alfa 2a 67 Intravitreal 67 selective A2A adenosine receptor 67 dimeglumine 67 Ophena TM 67 liposome injection 67 MAGE A3 ASCI 67 PEGylated anti 66 Hormone Refractory Prostate Cancer 66 Teriflunomide 66 Tezampanel 66 Pivotal Phase III 66 PSMA ADC 66 Pegasys peginterferon alfa 2a 66 limiting toxicity DLT 66 peginterferon alpha 2a 66 pegylated interferon alfa 2a 66 melphalan prednisone 66 Xelox 66 LAB CGRP 66 Temsirolimus 66 ancrod 66 oral ridaforolimus 66 relapsed MM 66 Initiate Phase 66 mg q#h 66 maximally tolerated dose 66 galiximab 66 Hycamtin ® 66 Telithromycin 66 EOquin TM phase 66 ORENCIA R 66 prucalopride 66 selective modulator 66 Zemplar Capsules 66 Platinol ® 66 mitoxantrone plus 65 PEGylated interferon beta 1a 65 evaluating tivozanib 65 ORENCIA ® 65 denileukin diftitox 65 oral rivaroxaban 65 generation purine nucleoside 65 azilsartan medoxomil 65 Pharmacokinetics PK 65 PEGylated Fab fragment 65 TO AVOID PREGNANCY WHILE 65 Panzem R NCD 65 Multiple Ascending Dose 65 Proellex TM 65 Tipranavir 65 blinded randomized placebo controlled 65 REMINYL ® 65 HuMax EGFr 65 subcutaneously administered 65 Muraglitazar 65 dexamethasone intravitreal implant 65 intranasal formulation 65 Aptivus ® 65 DEB# 65 gemcitabine carboplatin 65 thalidomide Thalomid 65 inhaled treprostinil 65 plus COPEGUS 65 Mg Uk 65 EOquin TM 65 orally inhaled 65 docetaxel Taxotere 65 desvenlafaxine succinate 65 Glatiramer Acetate 65 pharmacodynamic PD 65 reactogenicity 65 estramustine 65 paclitaxel Taxol ® 65 weekly subcutaneous injections 65 Aclidinium 65 ritonavir boosted 65 Interferon beta 1a 65 certolizumab 65 Efficacy Results 65 Bevacizumab Avastin 65 sitaxsentan 65 Peginterferon alfa 2b 65 liposomal formulation 65 gemcitabine Gemzar 65 aripiprazole Abilify 65 unfractionated heparin UFH 65 forodesine 64 Mycophenolate Mofetil 64 salmeterol fluticasone 64 Meets Primary Endpoint 64 topical gel formulation 64 Levoleucovorin 64 neratinib 64 teriflunomide 64 ACTEMRA TM 64 treatment naive genotype 64 Vidaza azacitidine 64 refractory chronic lymphocytic 64 risedronate sodium tablets 64 PEG IFN 64 8mg/kg 64 preclinical efficacy 64 midstage clinical 64 CTAP# Capsules 64 multicenter Phase III 64 ara C 64 pegylated interferon alfa 64 lexidronam injection 64 serotonin norepinephrine reuptake inhibitor 64 icatibant 64 gemcitabine cisplatin 64 BENICAR HCT 64 ChronVac C R 64 Taxotere chemotherapy 64 Interferon alfa 64 Phase 2b Clinical Trial 64 docetaxel Taxotere ® 64 q#h 64 oral prodrug 64 Ziprasidone 64 TNF Tumor Necrosis Factor 64 Vandetanib 64 Completes Patient Enrollment 64 EURIDIS 64 antibody MAb 64 Bezielle 64 Study Evaluating 64 VELCADE melphalan 64 MGd 64 Azacitidine 64 SPRYCEL ® 64 adalimumab Humira 64 Gemzar gemcitabine 64 abacavir lamivudine 64 phase III isavuconazole 64 Degarelix 64 Pertuzumab 64 GAMMAGARD 64 1mg 2mg 64 cilengitide 64 GOUT 64 treatment naïve genotype 64 vapreotide acetate 64 ZD# [001] 64 colesevelam HCl 64 mg/m2 administered 64 APPRAISE 64 LEVAQUIN ® 64 pharmacologically active isomer 64 #mg dose [002] 64 Vildagliptin 64 3mg/kg 64 Doxil ® 64 5 Fluorouracil 64 5 fluorouracil leucovorin 64 ALGRX 64 Mg Usa 64 Peg IFN 64 Ozarelix 64 intravenous bolus 64 Toremifene 64 anastrazole 64 ZACTIMA 64 gemtuzumab ozogamicin 64 comparator arm 64 R Saizen R 64 octreotide acetate 64 Tanespimycin 64 CIMZIA TM 64 ONGLYZA saxagliptin 64 non nucleoside inhibitor 64 ARB telmisartan 64 Zorbtive TM 64 Flu Cy 64 Dacogen injection 64 HCV SPRINT 64 recurrent glioblastoma multiforme 64 SCIg 64 Peginterferon 64 Luteinizing Hormone Releasing Hormone 64 somatostatin analog 64 dose proportionality 64 pharmacokinetic PK study 64 pharmacodynamic properties 64 interferon alfa 2b 64 BRIM2 63 NATRECOR ® 63 liposomal doxorubicin 63 etanercept Enbrel 63 beta 1a 63 oral transmucosal 63 gadobutrol 63 Vernakalant 63 TORISEL TM 63 phase Ib 63 efficacy tolerability 63 omega interferon 63 Initiated Phase 63 Clevudine 63 vidofludimus 63 CIMZIA ™ 63 Investigational Oral 63 CANCIDAS 63 Kahalalide F 63 sorafenib tablets 63 adefovir dipivoxil 63 Eszopiclone 63 Pegylated Interferon 63 Safinamide 63 SNT-MC#/idebenone 63 Pharmacokinetic parameters 63 See CLINICAL PHARMACOLOGY 63 insulin glulisine 63 Hsp# Inhibitor 63 mycophenolate mofetil 63 Dose Ranging Study 63 ZOLINZA 63 bortezomib Velcade 63 UPLYSO 63 zoledronate 63 Ecallantide 63 RE SURGE 63 guanfacine extended release 63 ATACAND 63 trastuzumab Herceptin R 63 μg dose 63 interferon gamma 1b 63 Romiplostim 63 pharmacokinetics PK 63 morphometric vertebral fractures 63 albiglutide 63 oral diclofenac 63 bovine thrombin 63 tolerability profiles 63 pertuzumab 63 #mg #mg #mg [003] 63 sargramostim 63 dopamine partial agonist 63 Teysuno 63 doxorubicin cyclophosphamide 63 GW# [003] 63 PEGASYS ® 63 nitroprusside 63 Adenoscan R 63 Retisert R 63 metaglidasen 63 R# #mg BID 63 YONDELIS 63 Indomethacin 63 Forodesine HCl 63 novel VDA molecule 63 Combination REOLYSIN R 63 Panzem R 63 PEGINTRON TM 63 Sodium oxybate 63 Randomized Phase 63 mg administered orally 63 nucleotide analogue 63 transdermal estradiol 63 alpha 2a 63 Dynavax HBV vaccine 63 Presents Preclinical 63 High Dose quadruples 63 ELACYT 63 Camptosar ® 63 Lubiprostone 63 vivo preclinical 63 RAPAFLO R 63 Investigational Compound 63 plus prednisone 63 LymphoStat B belimumab 63 plus prednisone prednisolone 63 ULORIC 63 receptor inhibitor 63 Pivotal Phase 63 liposomal amphotericin B 63 Antitumor Activity 63 Dacogen decitabine 63 CYT# potent vascular disrupting 63 Interferon beta 1b 63 visilizumab 63 Adjunctive Therapy 63 urocortin 2 63 Glufosfamide 63 Phase Ib study 63 divalproex sodium 63 cromolyn sodium 63 investigational monoclonal antibody 63 selective phosphodiesterase 63 chemoradiation therapy 63 fluvastatin 63 efavirenz EFV 63 SIMCOR 63 primary hypercholesterolemia 63 investigational antiplatelet agent 63 DepoDur 63 TEMODAL 63 relapsing multiple sclerosis 63 DLTs 63 Golimumab 63 BENLYSTA ® 63 Bayer HealthCare Onyx Pharmaceuticals 63 methylnaltrexone bromide 63 CCR5 mAb 63 Increlex R 63 Phase Ib II 63 ® lenalidomide 63 docetaxel chemotherapy 63 administered subcutaneously 63 vinorelbine tartrate 63 hyaluronidase enzyme 63 monoclonal antibody conjugated 63 ® pioglitazone HCl 62 Phase 1a clinical 62 gemcitabine Gemzar ® 62 darunavir r 62 Cefazolin 62 alfuzosin 62 ribavirin USP 62 #I TM# 62 HMG CoA reductase inhibitors 62 CALGB # [002] 62 pomalidomide 62 topically administered 62 PREZISTA r 62 FUSILEV enhances 62 Onrigin 62 fluticasone furoate 62 PrevOnco ™ 62 basal bolus regimen 62 #mg BID [003] 62 PROVENGE ® 62 Cimzia TM 62 Teriparatide 62 L PPDS 62 Kinoid 62 Egrifta 62 temsirolimus 62 cytokine refractory 62 MYCAMINE 62 PegIFN 62 Amrubicin 62 pain palliation 62 dasatinib Sprycel ® 62 urate lowering 62 hydrochloride capsules 62 integrin inhibitor 62 herpetic keratitis 62 Tolvaptan 62 mg QD 62 intranasal delivery 62 posaconazole 62 Certolizumab pegol 62 AKT inhibitor 62 orally dosed 62 DepoDur TM 62 cyclophosphamide doxorubicin vincristine 62 systemically administered 62 pegylated interferon alpha 62 Initiate Clinical Trial 62 Ramelteon 62 Iloperidone 62 pegylated liposomal doxorubicin 62 Pegylated Liposomal Doxorubicin 62 QD dosing 62 oral methylnaltrexone 62 Silodosin 62 orally inhaled migraine 62 Torisel 62 Transdermal Patch 62 beta2 agonist 62 bepotastine besilate nasal spray 62 RoACTEMRA 62 TMC# r 62 standard chemotherapy regimen 62 Pharmacodynamic 62 Omacetaxine 62 DCCR 62 lanreotide 62 Prolongs Survival 62 Copegus ribavirin 62 tinidazole 62 bupropion SR 62 EmbraceAC 62 KRN# 62 Aliskiren 62 Tasigna nilotinib 62 AEGR 62 baminercept 62 aliskiren amlodipine 62 OMNARIS HFA 62 Boceprevir 62 Kamada AAT 62 pharmacodynamic parameters 62 inhalation powder 62 CIMZIA R 62 ritonavir boosted danoprevir 62 Prospective Randomized 62 candesartan cilexetil 62 Ranolazine 62 DexaSite 62 Daptomycin 62 G#DT 62 Pegasys ® 62 satraplatin Phase 62 amifostine 62 dosing cohort 62 Fluconazole 62 Irinotecan 62 daily Infergen 62 low dose cytarabine 62 receptor inhibiting monoclonal 62 LT NS# 62 Certolizumab 62 Lenalidomide 62 erlotinib Tarceva ® 62 dosing cohorts 62 Acute Ischemic Stroke 62 clevidipine 62 gp# vaccine 62 Cariprazine 62 Melphalan 62 Immunogenicity 62 PHX# 62 PRN FDA Approves 62 Saquinavir 62 Submits NDA 62 metastatic malignant 62 Phase Ib clinical 62 Nesiritide 62 Cloretazine 62 Parathyroid Hormone 62 pharmacokinetic PK profile 62 pregabalin Lyrica 62 #.#mg/kg [002] 62 glatiramer acetate 62 nicardipine 62 preclinical pharmacology 62 R roscovitine 62 Pazopanib 62 acyclovir Lauriad R 62 cysteamine bitartrate 62 EXPAREL TM 62 Ovitrelle R Serostim 62 statin monotherapy 62 Bosutinib 62 OvaRex MAb 62 calcineurin inhibitor 62 eribulin mesylate 62 Primary endpoints 62 Fludara 62 AGHD 62 Romidepsin 62 Qutenza TM 62 tacrolimus ointment 62 antiviral efficacy 62 Renal Impairment 62 subcutaneous SC 62 Elitek 62 FOLFOX6 62 MabCampath 62 Begins Dosing 62 mometasone furoate 62 MGN# 62 dose escalation phase 62 citalopram hydrobromide 62 #μg [002] 62 arsenic trioxide injection 62 Androxal TM 62 Aloxi injection 62 Inhalation Powder 62 sorafenib Nexavar ® 62 viral kinetics 62 administered concomitantly 62 Targretin capsules 62 Pegloticase 62 Eculizumab 62 Adjuvant Treatment 62 HBeAg + 62 BEXXAR Therapeutic Regimen 62 ribavirin RBV 62 rALLy trial 62 Denufosol 62 levocetirizine 62 Vicriviroc 62 #mg/day [002] 62 abacavir Ziagen 62 chlorambucil 62 CLARITY study 62 humanized therapeutic 62 dual endothelin receptor antagonist 62 docetaxel Taxotere R 62 reslizumab 62 Clolar ® 62 4mg/kg 62 fosbretabulin 62 intravitreal triamcinolone 62 HCl capsules 62 dose escalation clinical 62 nebulized formoterol fumarate 62 riociguat 62 Adefovir 62 Triapine R 62 pimecrolimus 61 Daclizumab 61 controlled multicenter Phase 61 Privigen 61 Nilotinib 61 pharmacokinetic profiles 61 Initiates Phase II 61 histone deacetylase inhibitor 61 randomized multicenter trial 61 TORISEL 61 intravitreal insert 61 IMiDs ® 61 Tumor Response 61 R abatacept 61 phase IIb III 61 Temodar ® 61 SinuNase TM 61 Linagliptin 61 administered intranasally 61 Octreolin 61 insulin glargine rDNA origin 61 Adalimumab 61 5mg #mg 61 bendamustine 61 GAMMAGARD LIQUID 61 Valtropin 61 nab paclitaxel 61 bevirimat Study 61 sunitinib malate 61 oral levofloxacin 61 Peginterferon Alfa 2a 61 Receives Orphan Drug Designation 61 ALN HPN 61 pioglitazone HCl 61 ceftazidime 61 randomized controlled Phase 61 seliciclib CYC# 61 novel histone deacetylase 61 Cetrorelix pamoate 61 interstitial brachytherapy 61 thetreatment 61 Nebulized 61 MKC# 61 alefacept 61 Fondaparinux 61 Tolerability 61 vinca alkaloid 61 Oral NKTR 61 lucinactant 61 Vitaxin 61 lenalidomide Revlimid R 61 mg TID 61 radiation sensitizer 61 tolerability pharmacokinetics 61 histamine dihydrochloride 61 mertansine 61 Vitrasert R 61 Presents Preclinical Data 61 Emtriva Viread 61 AAG geldanamycin analog 61 tipranavir r 61 orally administered inhibitor 61 Myocet 61 ug kg 61 Placebo Controlled Trial 61 fluticasone salmeterol 61 Dapagliflozin 61 Fulvestrant 61 mTOR inhibitor 61 TAXOTERE R 61 relapsed myeloma 61 CYT# QbG# 61 Hydrochlorothiazide 61 mometasone 61 5mg #mg #mg 61 hyperphenylalaninemia HPA due 61 MetroGel 61 administered intramuscularly 61 Dual Opioid 61 ACUROX ® 61 FEMALES SHOULD BE ADVISED 61 Elagolix 61 investigational antiplatelet 61 Initiates Enrollment 61 capsules USP 61 Eluting Coronary Stent System 61 Dyloject TM 61 COLAZAL R 61 mg/m2 dose 61 Roflumilast 61 RANK Ligand inhibitor 61 myelodysplastic myeloproliferative diseases 61 RECORD1 61 metformin HCl 61 lisdexamfetamine dimesylate 61 PEGylated interferon 61 active comparator 61 thorough QT 61 STELARA ™ 61 FDA APPROVES 61 cediranib 61 severe gastroparesis 61 aromatase inhibitor AI 61 IL# PE#QQR 61 #mg ATC 61 pharmacokinetic PK 61 inhaled iloprost 61 Toxoid 61 oral renin inhibitor 61 Oral Insulin 61 Tesamorelin 61 5 lipoxygenase inhibitor 61 antiarrhythmic drug 61 rifabutin 61 paclitaxel Taxol R 61 Roche Xeloda 61 combines bupropion 61 dasatinib Sprycel 61 Capsules CII 61 hormone agonist 61 atazanavir sulfate 61 INVEGA ® 61 Leukine ® 61 ß blockers 61 hemostatic efficacy 61 Xeloda capecitabine 61 induced macular edema 61 Topotecan 61 Successfully Completes Phase 61 Trobalt 61 GERD migraine headaches 61 Angiotensin Converting Enzyme 61 tigecycline 61 mg BID dose 61 alemtuzumab MS 61 hA# 61 Desvenlafaxine Succinate 61 AMEVIVE 61 Reports Preclinical Data 61 Moxifloxacin 61 ascending dose 61 selective estrogen receptor modulator 61 dexamethasone Decadron 61 ongoing Phase 1b 61 Pooled Analysis 61 Inhalation Solution 61 Decitabine 61 Oral Fingolimod 61 Phase 2b Study 61 Kepivance 61 Arikace 61 inhalations twice 61 Pentacel R 61 VFEND 61 Initiates Clinical 61 Sapacitabine 61 tiotropium bromide 61 humanised monoclonal antibody 61 GVAX ® 61 pegylated alpha interferon 61 SCH # 61 Hepatotoxicity 61 Quetiapine 61 Zalypsis 61 Randomized Double Blind 61 Cimzia ® certolizumab pegol 61 BeneFIX 61 CTA# Injection 61 oblimersen 61 KNS # 61 CRLX# 61 inhaled corticosteroid ICS 61 inhibitor RG# 61 insulin detemir 61 Phase IIb Trial 61 NPH insulin 61 intravenously administered 61 JAK Inhibitor 61 Tocilizumab 61 oxymorphone ER 61 hoFH 61 refractory CLL 61 Tyrosine Kinase Inhibitor 61 Orally administered 61 PRT# 61 multicenter randomized controlled 61 Non inferiority 61 ularitide 61 MKC# MT 61 transcranial Doppler ultrasound 61 SUTENT ® 61 pramlintide 61 Neulasta ® 61 Navelbine ® 61 RhuDex ® 61 TASKi3 61 Sirolimus eluting Coronary Stent 61 peginterferon alfa 61 Pancreas Cancer Vaccine 61 Dasatinib 61 Femara letrozole 61 EQUETRO 61 briakinumab 61 investigational immunotherapy 61 LEUKINE 61 LymphoStat B TM 61 elotuzumab 61 CHAMPION PCI 61 intratympanic 61 Capecitabine 61 boosted protease inhibitor 61 #/#mg 61 Velcade bortezomib 61 Pafuramidine 61 RhuDex R 61 phase IIb study 61 budesonide foam 61 PPAR gamma agonist 61 Proquin XR 61 CONCERTA 61 TYGACIL 61 mg/# h 61 davunetide intranasal AL 61 goserelin 61 Patients Treated With 61 dose dexamethasone 61 Tiotropium 61 TAXUS Liberte Long 61 Valdoxan 61 Certican 61 CINQUIL 61 Randomized Phase II 61 human IgG1 monoclonal 61 ergot derivatives 61 Albuferon TM 61 Noxafil 61 acadesine 61 Intravenous immunoglobulin 61 azacytidine 61 Phase IIA 61 selective agonist 61 Investigational Treatment 61 macrolide antibiotic 61 Phase III ADT 61 Increlex ® 61 trabectedin 61 eluting stent 61 novel oral anticoagulant 61 haematologic 61 Anturol TM 61 daily subcutaneous injections 61 mg BID 61 NeuroSTAT ® 61 lumiliximab 61 mcg kg 61 temozolomide Temodar 61 REYATAZ R 61 ORMD 61 BYETTA exenatide injection 61 HGS# 61 Ozurdex 61 intravenous dosing 61 nalbuphine ER 61 mcg dose 61 Atomoxetine 61 MERLIN TIMI 61 SIR Spheres 61 Methylnaltrexone 61 LUVENIQ 61 p# MAP kinase inhibitor 61 lead Aganocide compound 61 cariprazine 61 Relapsing Multiple Sclerosis 61 lapatinib Tykerb 61 Long Term Efficacy 61 Phase 1b clinical trials 60 GRNVAC1 60 successfully commercialize Iluvien 60 RISPERDAL ® 60 PDE4 inhibitor 60 TRELSTAR R 60 HCV RESPOND 2 60 tazobactam 60 O PPDS 60 Arranon 60 OvaRex ® MAb 60 Antiviral Activity 60 INC# 60 Enzyme Replacement Therapy 60 LibiGel Phase III 60 busulfan 60 mCi 60 Phase IIIb clinical 60 Plicera 60 TREDAPTIVE 60 ribavirin Copegus 60 Tigecycline 60 diarrhea predominant irritable 60 Phase III Pivotal 60 pan histone deacetylase 60 Pralatrexate 60 Darinaparsin 60 rabeprazole 60 Bendamustine 60 Mycamine 60 Fingolimod 60 Capesaris 60 Posaconazole 60 pharmacodynamic effects 60 Civacir 60 diabetic neuropathic pain 60 APTIVUS 60 MoxDuo IR 60 pegylated IFN 60 taxane resistant 60 gastrointestinal toxicities 60 QTc prolongation 60 weekly intravenous infusions 60 telomerase therapeutic 60 PD LID 60 Zybrestat 60 memantine Namenda 60 FDA Accepts 60 balsalazide tablet 60 Cloretazine R VNP#M 60 Myocardial Perfusion Imaging 60 Inhalation Aerosol 60 prulifloxacin 60 antiepileptics 60 sulodexide 60 UVIDEM 60 Interferon alpha 2b 60 ARCOXIA 60 diclofenac sodium 60 Sitagliptin 60 azelastine 60 DU #b 60 GLP toxicology studies 60 ALB # 60 Nitazoxanide 60 mapatumumab 60 ClearPath HDR 60 Initiates Clinical Trial 60 Soliris eculizumab 60 pegylated interferon alfa 2b 60 retinal vein occlusion induced 60 Cloretazine ® 60 IGF 1R inhibitor 60 pharmacokinetic equivalence 60 trastuzumab emtansine T DM1 60 Navelbine 60 acitretin 60 fluoropyrimidine 60 protease inhibitor PI 60 Topical Gel 60 hormone LHRH antagonist 60 investigational protease inhibitor 60 FOLFOX4 60 everolimus eluting stents 60 adjuvant cisplatin 60 Perforomist ™ Inhalation Solution 60 immune globulin intravenous 60 HEPLISAV TM 60 decitabine 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 IMPDH inhibitor 60 Phase #b/#a trial 60 iniparib 60 imipramine Tofranil 60 Alkeran 60 null responder 60 leukotriene receptor antagonists 60 Glypromate 60 Inosine 60 tolterodine ER 60 Budesonide 60 piroxicam 60 buccal spray 60 Initiates Phase 2b 60 Survivin antagonist 60 Sustiva efavirenz 60 NSABP B 60 Bazedoxifene 60 Alvesco R 60 prasugrel Effient 60 dose melphalan 60 Zarnestra 60 Arimoclomol 60 Q#IR 60 ARIXTRA R 60 BCX# 60 olopatadine 60 mitomycin 60 Hyphanox 60 endoscopic remission 60 ibandronate 60 aspirin clopidogrel 60 Naive Patients 60 favorable pharmacokinetic profile 60 intermittent dosing 60 Eraxis 60 Ticagrelor 60 GLP1 agonist 60 vildagliptin 60 miconazole Lauriad ® 60 quadrivalent HPV vaccine 60 Pfizer Camptosar 60 TLR9 agonist 60 amrubicin 60 PEG SN# 60 telaprevir dosed 60 formoterol fumarate 60 ospemifene 60 casopitant 60 Annamycin 60 HCV replicon 60 tocilizumab 60 Raptiva ® 60 multicenter randomized placebo controlled 60 pramlintide metreleptin combination 60 zileuton 60 FOLOTYN ® 60 pharmacokinetics pharmacodynamics 60 orally bioavailable 60 lopinavir r 60 OMS# 60 GSK# [001] 60 Double Blind Placebo 60 Pivotal Study 60 Prograf ® 60 DURIN TM 60 dosing frequency 60 immune modulating 60 Phase IIb Clinical Trial 60 BCR ABL inhibitor 60 #mg/#mg 60 ASCEND HF 60 bevacizumab Avastin R 60 Pharmacokinetic 60 velafermin 60 Betaferon R 60 Archexin 60 receptor blocker 60 Polymerase Inhibitor 60 TLK# 60 canakinumab 60 balsalazide 60 Ranibizumab 60 clomipramine 60 rosuvastatin Crestor 60 CRMD# 60 MVA HPV IL2 60 MAP# 60 Interferon alpha 60 rFSH 60 Twinrix 60 antifibrotic 60 vandetanib 60 Mitoxantrone 60 nucleoside analog 60 Toctino ® alitretinoin 60 refractory gout 60 CHOP chemotherapy 60 INCB# [001] 60 Cancidas 60 Virulizin ® 60 Infusion Reactions Severe 60 calcipotriene 60 Diabetic Macular Edema DME 60 VP# [004] 60 ACTOS ® 60 PRIALT 60 Neoadjuvant 60 #mg QD [002] 60 Preclinical Study 60 LEXIVA r 60 Epratuzumab 60 RAPTIVA